Adjuvant radiotherapy improves locoregional failure-free survival, compared with observation, in patients with locally advanced MIBC.

The approval was based on the C-POST study which evaluated cemiplimab in adults with CSCC at high risk of recurrence after surgery and radiation.

Adjuvant radiotherapy could substantially reduce risk for locoregional recurrence for patients with advanced muscle-invasive ...

The FDA has approved cemiplimab-rwlc for adjuvant treatment of adults with cutaneous squamous cell carcinoma at high risk for ...

“ounger patients with low genomic risk breast cancer may reasonably consider de-escalated adjuvant therapy,” the researchers wrote.

Dr. Justin Smith presented a secondary analysis of the TROG 08.03 RAVES trial evaluating quality of life after adjuvant or ...

Cemiplimab (Libtayo; Regeneron Pharmaceuticals) has been approved as an adjuvant treatment for adult patients with cutaneous ...

USA: Researchers have found in a new study that adjuvant radiotherapy (RT) or endocrine therapy (ET) significantly reduces ...

Delayed salvage radiotherapy may help selected patients after radical prostatectomy. Recent randomized trials have shown that following radical prostatectomy for prostate cancer, adjuvant radiotherapy ...

When hepatocellular carcinoma (HCC) is centrally adherent to major vessels, radiotherapy administered after surgery improves outcomes even in the setting of negative surgical margins, according to a ...

The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ fully human monoclonal antibody ...

Cyst: Cystectomy; Preop.: Preoperative radiotherapy. Radical cystectomy continues to be the treatment of choice for muscle-invasive bladder cancer. However, its treatment end results are still ...